The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A10 | Drugs used in diabetes | |
| 3 | A10B | Blood glucose lowering drugs, excl. insulins | |
| 4 | A10BJ | Glucagon-like peptide-1 (GLP-1) analogues | |
| 5 | A10BJ06 |
| Active Ingredient | Description | |
|---|---|---|
| Semaglutide |
Semaglutide is a GLP-1 receptor agonist. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps with the control of blood glucose levels. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| OZEMPIC Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| RYBELSUS Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| WEGOVY Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
